allopurinol 300 mg
INDICATIONS AND USAGE THIS IS NOT AN INNOCUOUS DRUG. IT IS NOT RECOMMENDED FOR THE TREATMENT OF ASYMPTOMATIC HYPERURICEMIA. Allopurinol tablets reduce serum and urinary uric acid concentrations. Its use should be individualized for each patient and requires an understanding of its mode of action and pharmacokinetics (see CLINICAL PHARMACOLOGY , CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS ). Allopurinol tablets are indicated in: 1. the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2. the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol tablets should be discontinued when the potential for overproduction of uric acid is no longer present. 3. the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.
arise pharamaceuticals llc
ROUND ORANGE I 136
I 136 ROUND ORANGE
Related Pills
allopurinol tablet
arise pharamaceuticals llc
allopurinol tablet
arise pharamaceuticals llc
probenecid 500 MG Oral Tablet
Marlex Pharmaceuticals Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED 100-mg (white to off white) scored, flat cylindrical tablets with "I" and "135" on either side of the break line on one side and plain on other side, bottles of 100 (NDC 69967-008-01), 500 (NDC 69967-008-02) and 1000 (NDC 69967-008-03). Store at 20° to 25°C (USP Controlled Room Temperature) (68° to 77°F) in a dry place. 300-mg (peach) scored, flat, cylindrical tablet with "I" and "136" on either side of the break line on one side and plain on other side, bottles of 100 (NDC 69967-009-01), 500 (NDC 69967-009-02)and 1000 (NDC 69967-009-03) . Store at 20° to 25°C (USP Controlled Room Temperature) (68° to 77°F) in a dry place and protect from light. Manufactured for: Arise Pharmaceuticals LLC 12 Roszel Road, Unit B202, Princeton, NJ 08543 Customer complaint toll free number: +1-855-642-2594 Manufactured by: Indoco Remedies Ltd. L-32, 33, 34, Verna Industrial Area, Verna Goa. 403 722, India. March 2020 PURINETHOL® (mercaptopurine) is registered Trademark of Teva Biologics and Specialty Products. IMURAN® (azathioprine) is registered Trademark of Prometheus Laboratories Inc.
More pills like ROUND I 136